Company · CIK 0001690585 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Dianthus Therapeutics, Inc. /DE/ · DNTH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $101.38 | $2,027,646 | 0 | −100% | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $17.88 | $357,600 | 20,000 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $106.41 | $2,460,690 | 4,000 | −85.3% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $20.63 | $477,047 | 27,124 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | — | — | 43,818 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | — | — | 87,500 | — | 10b5-1 |